Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control - Ponirakis, Georgios; Abdul‐Ghani, Muhammad A; Jayyousi, Amin; Zirie, Mahmoud A; Qazi, Murtaza; Almuhannadi, Hamad; Petropoulos, Ioannis N; Khan, Adnan; Gad, Hoda; Migahid, Osama; Megahed, Ayman; Al‐Mohannadi, Salma; et al. (Journal of diabetes investigation, 2021)
Keywords: Adolescent; Adult; Aged; Biomarkers - blood; Blood Glucose - analysis; Blood pressure; Body mass index; Case-Control Studies; Cholesterol; Clinical Trial; Clinical trials; Confocal microscopy; Cornea; Cornea - cytology; Cornea - innervation; Corneal confocal microscopy; Degeneration; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - pathology; Diabetic Neuropathies - epidemiology; Diabetic Neuropathies - pathology; Diabetic Neuropathies - prevention & control; Diabetic neuropathy; Exenatide; FDA approval; Female; Follow-Up Studies; Glycated Hemoglobin - analysis; Glycemic Control - standards; Hemoglobin; Humans; Hypoglycemic Agents - therapeutic use; Insulin; Lipoproteins; Male; Middle Aged; Nerve Fibers - physiology; Nerve Regeneration; Pain; Pain - epidemiology; Pain - pathology; Pain - prevention & control; Painful diabetic neuropathy; Perception; Peripheral neuropathy; Pioglitazone; Prognosis; Qatar - epidemiology; Questionnaires; Regeneration; Skin; Young Adult; Qatar; United Kingdom--UK; United States--US; Corneal confocal microscopy; Exenatide; Painful diabetic neuropathy